BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2482644)

  • 1. Hyperamylasemia with papillary serous cystadenocarcinoma of the ovary.
    Schlikker I; Nakad A; Gerbaux A; Azzouzi K; Kadou J; Lezaire P; Janssen A; Piessevaux H; Dive C
    Acta Clin Belg; 1989; 44(4):255-8. PubMed ID: 2482644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperamylasemia with papillary serous cystadenocarcinoma of the ovary.
    Hayakawa T; Kameya A; Mizuno R; Noda A; Kondo T; Hirabayashi N
    Cancer; 1984 Oct; 54(8):1662-5. PubMed ID: 6206939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of serous papillary cystadenocarcinoma of the ovary with hyperamylasemia].
    Nakamura S; Hirabayashi N; Asai J
    Gan No Rinsho; 1987 Apr; 33(4):428-33. PubMed ID: 2437341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperamylasemia associated with endometrioid carcinoma of the ovary: case report and immunohistochemical study.
    Yagi C; Miyata J; Hanai J; Ogawa M; Ueda G
    Gynecol Oncol; 1986 Oct; 25(2):250-5. PubMed ID: 2428702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serous papillary cystadenocarcinoma associated with alpha-fetoprotein production.
    Higuchi Y; Kouno T; Teshima H; Akizuki S; Kikuta M; Ohyumi M; Yamamoto S
    Arch Pathol Lab Med; 1984 Sep; 108(9):710-2. PubMed ID: 6205636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperamylasemia due to poorly differentiated adenosquamous carcinoma of the ovary.
    Norwood SH; Torma MJ; Fontenelle LJ
    Arch Surg; 1981 Feb; 116(2):225-6. PubMed ID: 6162432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An amylase-producing serous cystadenocarcinoma of the ovary.
    Hodes ME; Sisk CJ; Karn RC; Ehrlich CE; Lehrner LM; Roth LM; Morley DJ; Merritt AD
    Oncology; 1985; 42(4):242-7. PubMed ID: 2409494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neoplasm of the ovary as a cause of hyperamylasemia].
    Pose Reino A; Suárez Dono J; Codesido Blanco T; Ferrón Vidán F; Lorenzo González A; Bugallo Paz L
    An Med Interna; 1989 Apr; 6(4):207-8. PubMed ID: 2485076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperamylasemia associated with endometroid carcinoma of the ovary.
    Juang CM; Yeng MS; Twu NF; Chao GC
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Sep; 63(9):710-3. PubMed ID: 11037648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amylase activity and fast-migrating amylase isoenzymes in serum and cyst fluid from patients with ovarian neoplasms.
    Henriksen R; Brock A
    Acta Obstet Gynecol Scand; 1988; 67(1):65-70. PubMed ID: 2459898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multidisciplinary approach to an unusual cause of hyperamylasaemia.
    Logie JJ; Cox M; Sharkey J; Williams A
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26150631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperamylasemia in cystadenocarcinoma of the ovaries].
    Naess CE; Naess MH; Landmark K; Tjora S
    Tidsskr Nor Laegeforen; 1984 Aug; 104(23):1536-7. PubMed ID: 6207603
    [No Abstract]   [Full Text] [Related]  

  • 13. Amylase in serous ovarian neoplasms.
    Ramaswamy G; Jagadha V; Tchertkoff V
    N Y State J Med; 1985 Mar; 85(3):113-5. PubMed ID: 2581198
    [No Abstract]   [Full Text] [Related]  

  • 14. The mechanism of increased renal clearance of amylase in acute pancreatitis.
    Warshaw AL; Lee KH
    Gastroenterology; 1976 Sep; 71(3):388-91. PubMed ID: 950087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian carcinomatosis presenting with hyperamylasemia and pleural effusion.
    Shapiro R; Dropkin R; Finkelstein J; Aledort D; Greenstein AJ
    Am J Gastroenterol; 1981 Oct; 76(4):365-8. PubMed ID: 6172979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sialyl salivary-type amylase associated with ovarian cancer.
    Moriyama T
    Clin Chim Acta; 2008 May; 391(1-2):106-11. PubMed ID: 18294455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of amylase-producing ovarian tumor].
    Tanaka Y; Ueda G; Tanizawa O; Miyake H; Kohno M; Nishiyama S; Inoue H; Ikeuchi H; Sekigawa S; Matsunaga S
    Gan No Rinsho; 1986 Jan; 32(1):111-6. PubMed ID: 2419596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alterations in the activity of amylase and its salivary isoenzyme in the serum of patients with ovarian carcinoma, submitted to radiotherapy.
    Zakrzewska I; Pietryńczak M
    Rocz Akad Med Bialymst; 1997; 42(1):229-35. PubMed ID: 9581485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperamylasemia and ovarian carcinoma.
    Sandiford JA; Chiknas SG
    Clin Chem; 1979 Jun; 25(6):948-50. PubMed ID: 445830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of electrophoretic pattern of amylase isoenzymes to severity of pancreatic disease.
    Otsuki M; Yuu H; Maeda M; Yamasaki T; Okano K; Sakamoto C; Baba S
    Clin Chim Acta; 1977 Aug; 79(1):1-6. PubMed ID: 890943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.